Top Stories

GSK buys Mevacor OTC rights

November 27, 2007

GlaxoSmithKline will buy the rights to market Merck's cholesterol-lowering drug Mevacor (lovastatin) over-the-counter (OTC) in the US, pending FDA approval. Financial terms of the deal were not disclosed.
 

FDA issues GSK a warning on Tykerb letters

November 27, 2007

The FDA slapped GlaxoSmithKline with a warning letter for a series of Dear Healthcare Practitioner letters promoting Tykerb.
 

GSK acquires Reliant in move to boost cardio franchise

November 26, 2007

In a move to bolster its cardiovascular product line, GlaxoSmithKline (GSK) has announced plans to purchase New Jersey-based Reliant Pharmaceuticals for $1.65 billion in cash.
 

In Other News

FDA to review use of asthma drugs in children

November 26, 2007

The FDA is recommending an additional safety review of GlaxoSmithKline's Serevent and Advair and Novartis' Foradil in children.
 

Product news

November 27, 2007

Bristol-Myers Squibb Company and Otsuka Pharmaceutical announced that the FDA approved the supplemental New Drug Application for Abilify (aripiprazole) as adjunctive, or add-on, treatment to antidepressant therapy in adults with major depressive disorder (MDD).
 

Account wins

November 27, 2007

Skura Corporation has announced the signing of a global agreement with Boehringer Ingelheim to provide the Skura SFX Suite as the preferred solution for closed loop marketing implementation in their subsidiaries.
 

Company news

November 27, 2007

Novo Nordisk signed an exclusive agreement with Sciele Pharma to market Prandin (repaglinide).
 

Webcast

5 BIG REASONS for taking pharmaceutical marketing online

Available on demand
Many pharmaceutical marketers are still unsure about entering the digital landscape and even less certain of what to do when they get there. Interactive marketing experts from Google and pharmaceutical companies discuss why marketers should take the plunge and how it could positively impact their businesses. Click here for more information and to register for this webcast. 

Sponsored by Google.

 



Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.